TY - JOUR
T1 - Corrigendum to “Three months extended-release microspheres prepared by multi-microchannel microfluidics in beagle dog models” [Int. J. Pharm. 608 (2021) 121039](S0378517321008450)(10.1016/j.ijpharm.2021.121039)
AU - Kim, Ju Hee
AU - Ryu, Choong Ho
AU - Chon, Chan Hee
AU - Kim, Seyeon
AU - Lee, Sangno
AU - Maharjan, Ravi
AU - Kim, Nam Ah
AU - Jeong, Seong Hoon
N1 - Publisher Copyright:
© 2021 Elsevier B.V.
PY - 2022/1/5
Y1 - 2022/1/5
N2 - The authors regret that the following text must be corrected since Fig. 3c, 3d, 4, 5d, and 5e were processed from the same raw data for one-month dog PK study published in the earlier article (https://doi.org/10.1016/j.ijpharm.2021.120527). The authors would like to apologise for any inconvenience caused. The corrected legends for Figs. 3, 4, and 5 are as below with the reference: Fig. 3. (a) Plasma drug concentration–time profiles after the administration of microspheres based on the ratio of 7502A:API (4:1) and 5002A:API (4:1), (b) cumulative plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1) and 5002A:API (4:1), (c) plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1), 7502A:API (2:1), and 7502A:API (2:1) with 20 mg API (71.4% of dose) (black line), and (d) cumulative plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1), 7502A:API (2:1), and 7502A:API (2:1) with 20 mg API (71.4% of dose) (black line). Each point represents the mean ± SD (n = 9). Red and blue lines in (c) and (d) were generated using the same raw data reported earlier (Kang et al., 2021). Fig. 4. (a) Plasma drug concentration–time profiles after the administration of microspheres based on 2.8 mg drug (10% of dose), 5.6 mg drug (20% of dose), 11.2 mg drug (40% of dose), 16.8 mg drug (60% of dose), and 28 mg drug (100% of dose), and (b) cumulative plasma drug concentration–time profiles after the administration of the microspheres. Each point represents the mean ± SD (n = 5). Results were generated using the same raw data reported earlier (Kang et al., 2021). Fig. 5. (d) Plasma concentration of 1 mg Propecia® tablet, and (e) 1 month simulation study of the plasma concentration of the drug-loaded microspheres injectable. Each point represents the mean ± SD (n = 5). (d) and (e) were generated using the same raw data reported earlier (Kang et al., 2021).
AB - The authors regret that the following text must be corrected since Fig. 3c, 3d, 4, 5d, and 5e were processed from the same raw data for one-month dog PK study published in the earlier article (https://doi.org/10.1016/j.ijpharm.2021.120527). The authors would like to apologise for any inconvenience caused. The corrected legends for Figs. 3, 4, and 5 are as below with the reference: Fig. 3. (a) Plasma drug concentration–time profiles after the administration of microspheres based on the ratio of 7502A:API (4:1) and 5002A:API (4:1), (b) cumulative plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1) and 5002A:API (4:1), (c) plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1), 7502A:API (2:1), and 7502A:API (2:1) with 20 mg API (71.4% of dose) (black line), and (d) cumulative plasma drug concentration–time profiles based on the ratio of 7502A:API (4:1), 7502A:API (2:1), and 7502A:API (2:1) with 20 mg API (71.4% of dose) (black line). Each point represents the mean ± SD (n = 9). Red and blue lines in (c) and (d) were generated using the same raw data reported earlier (Kang et al., 2021). Fig. 4. (a) Plasma drug concentration–time profiles after the administration of microspheres based on 2.8 mg drug (10% of dose), 5.6 mg drug (20% of dose), 11.2 mg drug (40% of dose), 16.8 mg drug (60% of dose), and 28 mg drug (100% of dose), and (b) cumulative plasma drug concentration–time profiles after the administration of the microspheres. Each point represents the mean ± SD (n = 5). Results were generated using the same raw data reported earlier (Kang et al., 2021). Fig. 5. (d) Plasma concentration of 1 mg Propecia® tablet, and (e) 1 month simulation study of the plasma concentration of the drug-loaded microspheres injectable. Each point represents the mean ± SD (n = 5). (d) and (e) were generated using the same raw data reported earlier (Kang et al., 2021).
UR - https://www.scopus.com/pages/publications/85121001330
U2 - 10.1016/j.ijpharm.2021.121267
DO - 10.1016/j.ijpharm.2021.121267
M3 - Comment/debate
C2 - 34802796
AN - SCOPUS:85121001330
SN - 0378-5173
VL - 611
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
M1 - 121267
ER -